Skip to main content

WPI 2285 Pill - white capsule/oblong, 22mm

Pill with imprint WPI 2285 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 225 mg. It is supplied by Actavis Pharma, Inc.

Propafenone is used in the treatment of Atrial Fibrillation; Atrial Flutter; Ventricular Tachycardia; Wolff-Parkinson-White Syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2285

Propafenone hydrochloride extended-release 225 mg WPI 2285
Propafenone hydrochloride extended-release 225 mg WPI 2285

Propafenone Hydrochloride Extended-Release

WPI 2285
225 mg
22.00 mm
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
ferrosoferric oxide, gelatin, hypromelloses, magnesium stearate, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulfate, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "WPI 2285"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.